Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis.
Three hundred and eight nanometre excimer light has been reported to be safe and effective in the treatment of chronic skin diseases, but the range of potential applications has not been fully explored. Our objective was to assess the efficacy of monochromatic excimer light (MEL) in the treatment of prurigo nodularis (PN). Eleven patients were enrolled in this pilot study. Patients were treated weekly and an average of eight sessions of MEL was given. Follow-up was 4 months. Partial or complete clinical and histological remission was observed in all patients who completed the study (81%).
Saraceno
Rosita
R
Department of Dermatology, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy. rositasaraceno@yahoo.it
Nisticò
Steven P
SP
Capriotti
Elisabetta
E
de Felice
Catia
C
Rhodes
Lesley E
LE
Chimenti
Sergio
S
D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011536:Prurigo / Q000473:pathology / Q000532:radiotherapy*; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014467:Ultraviolet Therapy